biote Corp.

NASDAQ:BTMD

Medical - Care Facilities

Healthcare
$1.23 +0.22%

+$0.01 today

Market cap
$54.25M
Beta
1.66
P/E (TTM)
4.5
EPS (TTM)
$0.51
52W Low $1.27High $4.75

Volume 0.11M

Average 0.25M

BTMD Other Stockholders Equity

Equity items not reported separately, such as additional paid-in capital or treasury stock.

biote Corp.NASDAQ: BTMD

Other Stockholders Equity · Q1 FY2026 · quarter ended Mar 2026

Other stockholders equity remains negative

Q1 FY2026 other stockholders equity was $0, compared with $0 a year earlier.

Context

  • Other stockholders equity amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Other stockholders equity increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Other Stockholders Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Stockholders Equity history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Other Stockholders Equity vs competitors

How BTMD compares with its peers on the latest reported figures

  • BTMD's Mar 2026 other stockholders equity of $0 is the highest of the 11 companies compared; the peer median is $0.
  • Other stockholders equity amounts to 0.0% of total assets for BTMD, versus a peer median of 0.0%.
BTMD Competitors Peer median
Other Stockholders Equity for BTMD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BTMDbiote Corp.Mar 2026$0 ——0.0%
VORVor Biopharma Inc.Mar 2026$0 ——0.0%
ANIKAnika Therapeutics, Inc.Mar 2026$0 ——0.0%
ABOSAcumen Pharmaceuticals, Inc.Mar 2026$0 ——0.0%
LUCDLucid Diagnostics Inc.Mar 2026$0 ——0.0%
JYNTThe Joint Corp.Mar 2026$0 ——0.0%
INOInovio Pharmaceuticals, Inc.Mar 2026$0 ——0.0%
SPROSpero Therapeutics, Inc.Mar 2026$0 ——0.0%
SCLXScilex Holding CompanyMar 2026$0 ——0.0%
MCRBSeres Therapeutics, Inc.Mar 2026$0 ——0.0%
ACTUActuate Therapeutics IncMar 2026$0 ——0.0%
Peer median (excluding BTMD) $0——0.0%

Competitors are the stored peer set for BTMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents26.77M79.23M89M39.34M24.12M
Short-term Investments00000
Net Receivables5.23M6.95M8.17M7.7M7.68M
Inventory9.62M11.18M17.31M14.85M19.06M
Other Current Assets3.94M0308K111K10K
Total Current Assets47.09M101.18M122.34M68.13M54.67M
Property, Plant & Equipment (Net)2.69M3.56M3.1M10.22M13.45M
Goodwill0005.83M5.83M
Intangible Assets4.55M5.07M4.97M9.38M4.27M
Long-term Investments00000
Tax Assets01.84M24.88M28.74M24.79M
Other Non-current Assets00072K4.6M
Total Non-current Assets7.25M10.47M32.95M54.24M52.94M
Total Assets54.33M111.65M155.3M122.37M107.61M
Account Payables4.35M4.11M4.16M5.81M6.83M
Short-term Debt5M6.25M6.25M6.25M6.25M
Tax Payables01.05M17K00
Deferred Revenue1.71M1.97M3M2.96M3.02M
Other Current Liabilities2.21M4.22M6.07M30.32M22.5M
Total Current Liabilities17.31M18.77M22.22M51.51M44.99M
Long-term Debt31.96M112.09M106.63M101.2M100.78M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)802K926K1.32M1.55M1.1M
Other Non-current Liabilities802K36.21M59.99M67.41M8.84M
Total Non-current Liabilities32.89M151.15M169.63M173.06M113.02M
Total Liabilities50.21M169.92M191.84M224.57M158.01M
Common Stock06K6K4K4K
Retained Earnings4.17M(44.46M)(29.39M)(100.3M)(49.55M)
Accumulated OCI(40K)(5K)(12K)(35K)(29K)
Other Stockholders Equity00000
Minority Interest0(13.82M)(7.15M)3.73M8.14M
Total Equity4.13M(58.27M)(36.55M)(102.2M)(50.4M)
Total Debt37.34M120.43M114.87M110.86M109.92M
Net Debt10.57M41.2M25.87M71.52M85.8M

biote Corp.

NASDAQ:BTMD

Intrinsic Alpha fair value

Locked

Current Price

$1.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.